INTRODUCTION
The prevalence of dementia is expected to triple by the year 2050, when there will be over 115 million people in the world suffering from dementia (1) . High serum cholesterol concentration is a known risk factor not only for cardiovascular diseases (CVD) (2) , but also for dementia (3) . Furthermore, Alzheimer's disease (AD) and CVD share the same risk gene, apolipoprotein E ε4 (Apo-E4) (4) . The prevalence of Apo-E4 varies worldwide (5) , but in Finland one third of the population has at least one of the ε4 alleles (6) .
Egg has traditionally been stigmatised with warnings because of its high content of cholesterol, but recent studies have challenged the role of dietary cholesterol or egg intakes in disease etiology (7, 8) . For most people the effect of dietary cholesterol on plasma cholesterol level is minor (9) , and cholesterol or egg intakes have not been found to associate with CVD risk in general populations (8, 10, 11) . The impact of dietary cholesterol on serum cholesterol is enhanced among the Apo-E4 carriers (12) , but dietary cholesterol or egg intakes have not been associated with higher CVD risk among them, either (13) . There is a limited number of studies concerning the impact of dietary cholesterol on dementia risk, and most have been conducted using animals. These experiments have shown an association between dietary cholesterol and AD type pathologies (14) (15) (16) (17) (18) , but such associations have not been demonstrated in human studies (19, 20) . To the best of our knowledge, the impact of egg intake on incident dementia risk has not been studied before, although some studies have found a beneficial association with mild cognitive impairment (21, 22) .
In this study we examined the associations of cholesterol and egg intakes with incident dementia among 2497 men from eastern Finland. In a subset of 1259 men, we investigated whether Apo-E4 phenotype modifies the associations. We also examined the associations of cholesterol and egg intakes with cognitive performance four years after the baseline examinations in a subset of 480 men.
SUBJECTS & METHODS Study population
The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) was designed to investigate risk factors for CVD, atherosclerosis, and related outcomes in a prospective, population-based sample of men from eastern Finland (23) . The baseline examinations were carried out in [1984] [1985] [1986] [1987] [1988] [1989] . A total of 2682 men aged 42, 48, 54 or 60 years at baseline (82.9% of those eligible) were recruited in two cohorts (Supplemental Figure) . The first cohort consisted of 1166 men who were 54 years old, enrolled in [1984] [1985] [1986] , and the second cohort included 1516 men who were 42, 48, 54 or 60 years old, enrolled in 1986-1989. The baseline examinations were followed by the 4-year examination round in 1991-1993, in which 1038 men from the second cohort (88% of the eligible) participated. The baseline characteristics of the entire study population have been described (24) . The KIHD protocol was approved by the Research Ethics Committee of the University of Kuopio. All subjects gave written informed consent for participation.
Cholesterol and egg intakes and dementia incidence
Subjects with history of mental problem (including dementia) at baseline (n=144), or with missing data on diet (n=41) were excluded, leaving 2497 men for the analyses with incident dementia.
Cholesterol and egg intakes and dementia incidence, influence of Apo-E phenotype
The Apo-E phenotype was determined from blood samples of 1033 men who participated in the 4-y examinations and from 307 other men from the baseline examinations, for whom blood samples for phenotyping were available. Among these 1340 men, subjects with history of mental problem at baseline (n=70), or with missing information on diet (n=11) were excluded, leaving 1259 men for the analyses with incident dementia. Compared to those without data on the Apo-E phenotype, those with this data were in general healthier and had a more favorable lifestyle and dietary habits, although their serum lipid and lipoprotein profile was less favorable (13) .
Cholesterol and egg intakes and cognitive performance
The cognitive performance tests at the 4-y examinations in 1991-1993 were performed by 519 men out of the 555 men who belonged to the two oldest age groups at the baseline examinations in 1986-1989, i.e. those who were 54 or 60 y old. Among those we excluded men with a history of mental problem (n=31), or missing information on diet (n=6) or on Apo-E phenotype (n=2), leaving 480 men for the analyses. We did not have data on cognitive performance tests at the baseline.
Assessment of dietary intakes
Consumption of foods was assessed at baseline in 1984-1989 with guided food recording of four days, of which one was a weekend day, by household measures. A picture book of common foods and dishes was used to help in estimation of portion sizes. The picture book contained 126 most common foods and drinks consumed in Finland, and for each food item the participant could choose from 3-5 commonly used portion sizes or describe the portion size in relation to those in the book. In order to further improve accuracy, instructions were given and completed food records were checked by a nutritionist together with a participant. Nutrient intakes were estimated using the NUTRICA® 2.5 software (Social Insurance Institution, Turku, Finland). The databank of the software is mainly based on Finnish values of nutrient composition of foods. The nutrient intakes were energy-adjusted by using the residual method. The egg consumption variable represents total egg consumption, including eggs in mixed dishes and recipes.
Measurements
Venous blood samples were collected between 8AM and 10AM at the baseline examinations in 1984-1989. Subjects were instructed to abstain from ingesting alcohol for three days and from smoking and eating for 12 hours prior to giving the sample. Detailed descriptions of the determination of serum lipids and lipoproteins (25) , assessment of medical history and medications at baseline (25) , family history of diseases (25) , smoking (25) , alcohol intake (25) , blood pressure (25) , and physical activity (26) , have been published. Serum high-sensitivity C-reactive protein (CRP) was measured with an immunometric assay (Immulite High Sensitivity CRP Assay, DPC, Los Angeles, CA, USA). Education was assessed in years by using self-administered questionnaire. The Apo-E phenotype was determined from plasma with isoelectric focusing and immunoblotting techniques. Subjects who had the phenotype 3/4 or 4/4 were included in the Apo-E4 group.
Neuropsychological tests
Cognitive function at the 4-y examinations in 1991-1993 was measured using five neuropsychological tests: the Mini Mental State Exam, the Trail Making Test, the Verbal Fluency Test, the Selective Reminding Test, and Russell's adaptation of the Visual Reproduction Test (27) (28) (29) (30) (31) . The tests were administered by interviewers trained in neuropsychological assessment. Each of the tests has been validated in the Finnish population (32) .
The Mini Mental State Exam has been widely used in both population-based and clinical research to test for the presence of cognitive impairment and as a screening tool for dementia.
The test assesses orientation (10 items), registration (3 items), attention and calculation (5 items), recall (3 items) and language (9 items). A correct response to each item scores 1 (incorrect 0) which are summed to give a potential maximum score of 30. Higher scores indicate better cognitive function.
The Trail Making Test is a test of frontal lobe functioning as indicated by perceptual motor speed, visual searching and sequencing, and the ability to make alternating conceptual shifts (33) . The original version of the test consisted of two parts (A and B), but in the current study we used the part A. Performance was judged in terms of the number of seconds required to complete the test.
The Verbal Fluency Test is a test of language performance that assesses the participant's ability to spontaneously produce words under the restrictions of a limited letter category and is also a test of frontal lobe functioning, particularly the left frontal lobe (33) . Participants were asked to generate as many words as possible beginning with the letters P, A and S: 60 seconds was allocated for each letter. Different forms of the same word and proper names of people or places were not counted as correct. Performance was assessed by counting the number of words produced during the 3-minute period, with higher scores indicating better language facility.
The Selective Reminding Test examines storage, retention and retrieval of information from short-and long-term memory and learning ability. Participants were initially read ten unrelated words in approximately 20 seconds and asked to recall the entire list in any order. Participants were then read only those words that they failed to recall after the first reading and were again asked to recall the entire list of ten words. This procedure was repeated six times and the participant's score was the total number of words recalled correctly (potential maximum score of 60).
Russell's adaptation of the Visual Reproduction Test examines visual memory for nonrepresentative figures (right temporal lobe functioning) and constructional ability. Participants were initially shown a single geometric figure for 10 seconds, after which it was removed from view: the participant was then required to draw the figure from memory. This procedure was repeated with a figure of greater complexity, and then for a third time, although on this occasion the participant was asked to draw two figures. Scoring was based on the degree to which the participant was able to correctly and accurately replicate the figures (potential maximum score of 21).
Ascertainment of follow-up events
Three national health registers were used to identify incident cases of dementia or AD in the KIHD cohort by the end of the year 2014. Computer linkages to the Care Register (hospital discharge data) (34) and Causes of Death register (35) were applied using ICD-8 code 290, ICD-9 codes 4378A and 290, and ICD-10 codes F00, F01, F02, F03, G30, and G31 to identify persons with dementia and ICD-8 codes 29000 and 29010, ICD-9 codes 290 and 3310A, and ICD-10 codes F00 and G30 for cases of AD. Since 1999, few years after the first drugs for symptomatic treatment of AD were launched, diagnosis of AD was recorded in the Special Reimbursement Register (SRR) maintained by the Social Insurance Institution (SII) of Finland. SRR is often used as a clinical epidemiology data source for studies on specific chronic conditions (36, 37) , including the prevalence and incidence of AD (38, 39) . To receive a special reimbursement right the patient has to be examined, diagnosed and given a certificate by a medical doctor, usually a specialist. For a diagnosis of AD to be verified and recorded in the Special Reimbursement Register the following conditions are required to meet: the person has (i) symptoms consistent with AD, (ii) experienced a decrease in social capacity over a period of at least 3 months, (iii) received a CT or MRI scan, (iv) had possible alternative diagnoses excluded, and (v) received confirmation of the diagnosis by a registered neurologist or geriatrician. Each medical certificate is then assessed by the SII to ensure that a patient meets the diagnostic criteria for AD of the Diagnostic and Statistical Manual Version IV (DSM-IV) and NINCDS-ADRDA for AD (40) (41) (42) . Persons with mixed dementias of the AD/vascular and AD/Lewy body are also recorded. Linkage to SRR was also used in the present study and it proved to be strongest method to identify cases with AD in the KIHD cohort.
Statistical analysis
The univariate relationships between cholesterol and egg intakes and baseline characteristics were assessed by means and linear regression (for continuous variables) or χ 2 -tests (for bivariate relationships). Cox proportional hazards regression models were used to estimate hazard ratios (HR) for incident dementia and AD in quartiles of baseline cholesterol and egg intakes. The validity of the proportional hazards assumption was evaluated by using Schoenfeld residuals. The associations of the baseline cholesterol and egg intakes with cognitive performance tests at the 4-y examinations were analyzed with the analysis of covariance. The confounders in the analyses were selected based on established risk factors for dementia, previously published associations with dementia (3), or on associations with exposures or outcomes in the present analysis. The Model 1 included age (years), examination year and energy intake (kcal/day). The multivariable model (Model 2) included the Model 1 and education years, smoking (cigarette packs/day x years of smoking), body mass index (kg/m 2 ), diabetes (yes/no), leisure-time physical activity (kcal/day), history of coronary artery disease (yes/no), lipid-lowering medication during follow-up (yes/no), and intakes of alcohol (g/week), fruits, berries and vegetables (g/day), carbohydrates (percent of energy), and fiber (g/day). The Model 3 was adjusted for the Model 2 and mutually either for egg (g/day) or cholesterol intake (mg/day). Further adjustment for history of stroke, systolic or diastolic blood pressure, hypertension medication, blood glucose, serum long-chain omega-3 polyunsaturated fatty acids, or intakes of coffee, saturated fatty acids or polyunsaturated fatty acids did not appreciably affect the associations (change in estimates <5%). All quantitative variables were entered as continuous variables.
Cohort mean was used to replace missing values in covariates (<3.4%). Statistical significance of the interactions on a multiplicative scale was assessed by stratified analysis and likelihood ratio tests using a cross-product term. Tests of linear trend were conducted by assigning the median values for each category of exposure variable and treating those as a single continuous variable. All P values were 2-tailed (α=0.05). Data were analyzed using SPSS 21.0 for Windows (Armonk, NY: IBM Corp. United States).
RESULTS

Baseline characteristics
The mean energy-adjusted cholesterol intake was 401 mg/d (SD 107), and the mean egg intake was 32 g/d (SD 25) (about 4 medium-sized eggs/week). Cholesterol intake from eggs (mean 110 mg/d, SD 81) accounted for 27% of the total cholesterol intake. Forty-eight percent (n=1199) consumed at least one half an egg (27 g)/day. Only 27 subjects (1.1%) did not consume eggs at all and three subjects reported using egg whites only.
Men with a higher cholesterol intake were less physically active, less educated, and were more likely to smoke and less likely to have hypertension ( Table 1) . They had higher total, LDL and HDL cholesterol concentrations, but lower serum triglyceride concentration. Their serum long-chain n-3 polyunsaturated fatty acid concentration was higher. They also had a higher intake of protein, saturated fatty acids, monounsaturated fatty acids, processed red meat, and lower intake of carbohydrates, fiber, polyunsaturated fatty acids, trans fatty acids, and fruit, berries, and vegetables. Those with a higher egg intake were younger, less likely to smoke, have hypertension or a history of a coronary artery disease, and their serum CRP concentration and diastolic blood pressure were lower (Table 1) . They had higher serum HDL cholesterol and lower serum triglyceride concentrations. They also had a higher intake of energy, fiber, saturated fatty acids, monounsaturated fatty acids, cholesterol, dairy, and coffee, and lower intakes of carbohydrates and polyunsaturated fatty acids.
Cholesterol and egg intakes and risk of any incident dementia
During the mean follow-up of 21.9 years (SD 7.9), 337 men (13.5%) were diagnosed with any incident dementia. Cholesterol intake was not associated with the risk of incident dementia ( Table 2) . Egg intake had a trend towards lower risk after multivariable adjustments (HR in the highest vs. the lowest quartile=0.74, 95% CI: 0.53, 1.02, P-trend across quartiles 0.04, Model 2), but the association was not statistically significant after adjustments for cholesterol intake (P-trend=0.20, Model 3). Evaluated continuously, each 100 mg/day higher cholesterol intake was associated with a multivariable-adjusted HR=0. In the subset of 1259 men, 29.6% had the Apo-E 3/4 phenotype and 3.6% had the 4/4 phenotype ( Table 3) . After adjustment for age and examination year, those with the Apo-E4 phenotype had 97% (HR=1.97, 95% CI: 1.46, 2.65) higher risk of any incident dementia compared to the Apo-E4 non-carriers. After multivariable adjustments (Model 2), the HR was 1.97 (95% CI: 1.45, 2.68). However, the Apo-E4 phenotype did not modify the associations of either cholesterol (P-interaction=0.62, Model 2) or egg intakes (P-interaction=0.95) with the risk of incident dementia.
Cholesterol and egg intakes and risk of AD
In the analyses with incident AD diagnosis as the outcome (266 events), the HR=0.79 (95% CI: 0.53, 1.19; P-trend=0.29) for the highest vs. the lowest cholesterol intake quartile and HR=0.85 (95% CI: 0.59, 1.23; P-trend=0.34) for the highest vs. the lowest egg intake quartile (Model 2). The associations were again attenuated after mutual adjustments (data not shown).
In the subset of 1295 men, Apo-E4 phenotype did not modify the associations of either cholesterol (P-interaction=0.87, Model 2) or egg intakes (P-interaction=0.52) with incident AD, although those with the Apo-E4 phenotype had 127% higher risk for developing AD (140 AD events; HR=2.27, 95% CI: 1.62, 3.18).
Cholesterol and egg intakes and cognitive performance
In the subset of 480 men, there were no statistically significant associations between the baseline cholesterol intake and cognitive performance at the 4-y follow-up examinations, whereas higher egg intake was associated with better performance in the Trail-Making Test and Verbal Fluency Test (Table 4) . Further adjustment for cholesterol intake had little impact on the results for the Trail-Making Test (P-trend=0.04) or Verbal Fluency Test (Ptrend=0.03). Each additional half an egg/day was associated with 1.9 seconds better performance in the Trail Making Test (95% CI: 0, 3.8 seconds, Model 2) and with 1.2 words better score (95% CI: -0.1, 2.4 words) in the Verbal Fluency Test. Again, the Apo-E4 phenotype did not modify the association of cholesterol (P-interactions >0.11) or egg intakes (P-interactions >0.24).
Sensitivity analyses
We investigated the impact of excluding men with coronary artery disease at baseline (n=613), because they might have changed their dietary habits after the coronary artery disease event, which could explain the lower number of men with the history of coronary artery disease among those with higher egg intake (Table 1) . However, this did not have any major impact on the associations with incident events. For example, in these analyses (254 events) each 100 mg/day higher cholesterol intake was associated with a multivariableadjusted HR=0.89 (95% CI: 0.77, 1.03; Model 2) and each additional half an egg (27 g)/day was associated with HR=0.90 (95% CI: 0.78, 1.05; Model 2) for incident dementia. In the cognitive performance tests (n=335), the inverse associations of egg intake with the TrailMaking test and the Verbal Fluency Test were attenuated and no longer statistically significant. Each additional half an egg/day was associated with 1.4 seconds better performance in the Trail Making Test (95% CI: -0.9, 3.6 seconds, Model 2) and with 0.7 words better score (95% CI: -0.9, 2.3 words) in the Verbal Fluency Test (Model 2).
DISCUSSION
In this population-based cohort study among middle-aged and older men from eastern Finland, we found that higher cholesterol or egg intakes were not associated with higher risk of incident dementia. Instead, we found that higher egg intake was associated with better performance in two cognitive tests assessing frontal lobe and executive functioning, the Trail Making Test and the Verbal Fluency Test.
The evidence about the association between dietary cholesterol intake and the risk of dementia is controversial. In animal studies with mice, rats and rabbits, the association between high cholesterol intake and AD type pathologies has been found systematically (14) (15) (16) (17) (18) . However, the association has not been shown in humans (19, 20) . Regarding the association between dietary cholesterol and lower cognitive performance, at least three studies have been published, of which two found an association (43, 44) and one did not (45) . In our study, higher intake of dietary cholesterol had in general no association with cognitive performance or risk of incident dementia.
It is not clear why the associations between dietary cholesterol and dementia seem incoherent between animal and human studies. One explanation could be the different lipoprotein metabolism of rats, mice, rabbits, and humans (46) , and thus results obtained from animal studies are possibly not directly applicable to humans. Although the lipid metabolism of rabbits is more comparable to humans than the metabolism of rodents, there are still some differences. For instance, rabbits are sensitive to cholesterol, and a long-lasting diet containing more than 1% cholesterol results in abnormally high cholesterol concentrations in the plasma, levels which are not found in humans (46) . Another explanation could be that the dietary cholesterol does have an effect on the human brain but the pathological changes are so minor that they cannot be seen on magnetic resonance imaging or on clinical status. That could explain why there are some indications of the associations between dietary cholesterol and lower cognitive performance (43, 44) . However, this connection cannot be applied to eggs as such.
To the best of our knowledge, there is no prior evidence concerning the impact of egg intake on the risk of dementia. However, few studies have investigated the association between egg intake and mild cognitive impairment and those have found either no association (47), or eggs have had a beneficial association (21, 22) , as in our study. Nevertheless, all these previous publications covered a more limited number of tests compared to our study.
Eggs are a major source of dietary cholesterol as one egg contains about 200 mg cholesterol. However, the effects of eggs on health are difficult to determine only by its cholesterol content. Dietary cholesterol has only a minor effect on plasma cholesterol levels on the majority of people (9), and eggs are a source of many other nutrients and bioactive compounds than just cholesterol (48) . Egg contains high-quality protein, unsaturated fatty acids, chelators and all the necessary minerals and vitamins with the exception of vitamin C.
Its nutrient dense form may be a good source of energy for those who are at risk of malnutrition, such as elderly (49) . The bioactive compounds, such as lutein, zeaxanthin (50) and choline (51) may have some beneficial effects on inflammation (52) and intestinal cholesterol absorption (53) . The high intake of choline has also been associated with fewer errors in a test measuring cognitive capacity (21) , and in the current study population eggs have been associated with lower risk of type 2 diabetes (54). Overall, egg intake does not appear to be associated with elevated risk of CVD (8, 10, 11) or mortality (11) in general populations. The results are similar even in hyperresponders to dietary cholesterol, i.e. among the Apo-E4 carriers (13) . Our results indicate that moderate, up to one egg/day intake does not seem to increase the risk of cognitive decline, either.
In some studies, egg intake has been associated with unhealthy lifestyle factors, such as smoking, high intake of processed red meat and low intake of vegetables (55, 56) , which may have influenced the conclusions made on the health effects of eggs. In our study population such associations were not observed (Table 1) . On the contrary, higher intake of eggs was associated with some favorable health factors, such as lower serum CRP and lower likelihood to have hypertension.
The strength of our study is the detailed information about dietary intakes, which were assessed using a 4-day food record and which included data about eggs in mixed dishes and recipes. We also had detailed information about incident dementia diagnoses. The other strengths were the population-based recruitment, extensive database of potential confounders, and virtually no loss to follow-up in the analyses with incident dementia.
The potential limitation of the study was the lack of data on Apo-E4 phenotype for all participants. We also had information on the performance in the cognitive tests only for a small proportion of the participants, which limits the generalizability of those findings to the whole study population. The number of subjects was further reduced in the sensitivity analyses after excluding those with coronary artery disease at baseline, which may at least partly explain the attenuated associations between egg intake and the performance in the Trail-Making Test and the Verbal Fluency Test in those analyses. Dietary habits were assessed only at baseline, which may have attenuated the associations with the incident dementia during the long follow-up. Because the majority of the dementia events occurred towards the end of the follow-up as the men were getting older, we were unable to investigate the associations with a shorter follow-up without losing a significant number of events. For example, only 11 events occurred during the first 10 years of follow-up. However, cholesterol or egg intakes were not associated with worse performance in the cognitive tests at the 4-year examinations, either, which supports the lack of association with incident events. The scores in the cognitive performance tests at the 4-y examinations were relatively good, indicating a good cognitive ability of the participants at baseline. Therefore, our results may not be generalizable to study populations already exhibiting cognitive decline.
In conclusion, in the present study we found no indications of a relationship of dietary cholesterol intake or moderate egg consumption with increased risk of incident dementia. Instead, our results suggest that moderate egg intake may have a beneficial association with certain areas of cognitive performance. More studies in diverse study populations are needed to elucidate the impact of egg and cholesterol intakes on cognitive decline. 2 Values are hazard ratio (95% confidence interval), obtained from the Cox proportional hazards regression models. 3 Model 2 adjusted for the Model 1 and education, smoking, body mass index, diabetes, leisure-time physical activity, coronary artery disease history, lipid-lowering medication during follow-up, and intakes of alcohol, carbohydrates, fiber, and fruits, berries, and vegetables. 4 Model 3 adjusted for the Model 2 and either egg or dietary cholesterol intake. 1 Values are means (95% confidence interval), adjusted for age, examination year, education, smoking, body mass index, diabetes, leisure-time physical activity, coronary artery disease history, lipid-lowering medication during follow-up, and intakes of energy, alcohol, carbohydrates, fiber, and fruits, berries, and vegetables. The mean values and 95% confidence intervals were obtained using analysis of covariance.
Supplemental Figure I.
The timeline of the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). Percentages in the brackets indicate the proportion of the eligible participants that participated in the study visits. The red box indicates the examinations used in the current analysis.
